NEW YORK ( TheStreet) -- Orexigen Therapeutics (Nasdaq: OREX) hit a new 52-week low Friday as it is currently trading at $1.56, below its previous 52-week low of $1.57 with 432,680 shares traded as of 1:16 p.m. ET. Average volume has been 1.5 million shares over the past 30 days. Orexigen has a market cap of $76.9 million and is part of the health care sector and drugs industry. Shares are down 80% year to date as of the close of trading on Thursday. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
- Practice your OREX trading strategies and win cash in our stock game.